PT  - JOURNAL ARTICLE
AU  - Kim, Jonathan
AU  - Glass, Hannah C
AU  - Amorim, Edilberto
AU  - Rao, Vikram R
AU  - Bernardo, Danilo
TI  - Exploration of Short-range Neonatal Seizure Forecasting with Quantitative EEG Based Deep Learning
AID  - 10.1101/2023.08.01.23293285
DP  - 2023 Jan 01
TA  - medRxiv
PG  - 2023.08.01.23293285
4099  - http://medrxiv.org/content/early/2023/08/06/2023.08.01.23293285.short
4100  - http://medrxiv.org/content/early/2023/08/06/2023.08.01.23293285.full
AB  - Background In this study, we utilize robust feature selection of quantitative encephalography (QEEG) features for inclusion into a deep learning (DL) model for short-range forecasting of neonatal seizure risk.Methods We used publicly available EEG seizure datasets with a total of 132 neonates. The Boruta algorithm with Shapley values was used for QEEG feature selection into a convolutional long short-term memory (ConvLSTM) DL model to classify preictal versus interictal states. ConvLSTM was trained and evaluated with 10-fold cross-validation. Performance was evaluated with varying seizure prediction horizons (SPH) and seizure occurrence periods (SOP).Results Boruta with Shapley values identified statistical moments, spectral power distributions, and RQA features as robust predictors of preictal states. ConvLSTM performed best with SPH 3 min and SOP 7 min, demonstrating 80% sensitivity with 36% of time spent in false alarm, AUROC of 0.80, and AUPRC of 0.23. The model demonstrated ECE of 0.106, consistent with moderate calibration. Evaluation of forecasting skill with BSS under varying SPH demonstrated a peak BSS of 0.056 and a trend for decreasing BSS with increasing SPH.Conclusion Statistical moments, spectral power, and recurrence quantitative analysis are predictive of the preictal state. Short-range neonatal seizure forecasting is feasible with DL models utilizing these features.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by Regents of the University of California (Resource Allocation Program).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The source data used were publicly available before the initiation of the study and are available via the cited references.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors.